Jeffrey A. Gottlieb

6.6k total citations · 2 hit papers
73 papers, 5.2k citations indexed

About

Jeffrey A. Gottlieb is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jeffrey A. Gottlieb has authored 73 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 19 papers in Molecular Biology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jeffrey A. Gottlieb's work include Chemotherapy-induced cardiotoxicity and mitigation (10 papers), Cancer therapeutics and mechanisms (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Jeffrey A. Gottlieb is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (10 papers), Cancer therapeutics and mechanisms (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Jeffrey A. Gottlieb collaborates with scholars based in United States, Malaysia and Canada. Jeffrey A. Gottlieb's co-authors include Sidney Rosenheim, Jan Piťha, Edward A. Lefrak, Robert S. Benjamin, Benjamin Drewinko, Robert A. Minow, James K. Luce, Robert W. Talley, Catherine Hill and Emil J. Freireich and has published in prestigious journals such as New England Journal of Medicine, JAMA and PEDIATRICS.

In The Last Decade

Jeffrey A. Gottlieb

71 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A clinicopathologic analysis of adriamycin cardiotoxicity

1973 1.2k citations Jeffrey A. Gottlieb et al. Cancer profile →
Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma

1976 625 citations Jeffrey A. Gottlieb, Arthur Haut et al. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey A. Gottlieb United States	32	2.6k	1.8k	1.2k	1.0k	946	73	5.2k
Sewa S. Legha United States	46	4.0k 1.5×	850 0.5×	1.1k 0.9×	448 0.4×	1.7k 1.8×	138	6.4k
James L. Speyer United States	37	2.2k 0.8×	1.2k 0.7×	788 0.7×	473 0.5×	928 1.0×	94	4.4k
E Frei United States	42	2.2k 0.9×	372 0.2×	1.2k 1.0×	885 0.8×	1.8k 1.9×	104	6.1k
P Dombernowsky Denmark	45	4.4k 1.7×	661 0.4×	2.1k 1.7×	557 0.5×	1.6k 1.7×	195	6.7k
A.T. van Oosterom Netherlands	41	3.8k 1.4×	624 0.3×	2.9k 2.4×	958 0.9×	1.8k 1.9×	177	7.8k
Anthony Elias United States	50	5.9k 2.2×	833 0.5×	3.5k 2.9×	1.1k 1.1×	2.2k 2.3×	205	9.8k
E. Wiltshaw United Kingdom	43	2.8k 1.1×	269 0.2×	1.4k 1.1×	2.1k 2.0×	1.4k 1.5×	129	7.4k
Frankie A. Holmes United States	42	6.7k 2.6×	438 0.2×	1.3k 1.1×	939 0.9×	1.6k 1.7×	135	9.0k
Scott Wadler United States	43	4.5k 1.7×	556 0.3×	1.9k 1.6×	975 0.9×	2.0k 2.2×	192	8.1k
G. Bonadonna Italy	25	1.9k 0.7×	297 0.2×	585 0.5×	788 0.8×	468 0.5×	72	3.3k

Countries citing papers authored by Jeffrey A. Gottlieb

Since Specialization

Citations

This map shows the geographic impact of Jeffrey A. Gottlieb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Gottlieb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Gottlieb more than expected).

Fields of papers citing papers by Jeffrey A. Gottlieb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey A. Gottlieb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Gottlieb. The network helps show where Jeffrey A. Gottlieb may publish in the future.

Co-authorship network of co-authors of Jeffrey A. Gottlieb

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey A. Gottlieb. A scholar is included among the top collaborators of Jeffrey A. Gottlieb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey A. Gottlieb. Jeffrey A. Gottlieb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Minow, Robert A., et al.. (1978). QRS voltage change with adriamycin administration.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 62(6). 931–4. 30 indexed citations

Benjamin, Robert S., Laurence H. Baker, Robert M. OʼBryan, Thomas E. Moon, & Jeffrey A. Gottlieb. (1977). Advances in the Chemotherapy of Soft Tissue Sarcomas. Medical Clinics of North America. 61(5). 1039–1043. 5 indexed citations

Einhorn, Lawrence H., et al.. (1976). Improved chemotherapy for small-cell undifferentiated lung cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 235(12). 1225–9. 47 indexed citations

Gottlieb, Jeffrey A., Robert S. Benjamin, Laurence H. Baker, et al.. (1976). Role of DTIC (NSC-45388) in the chemotherapy of sarcomas.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 60(2). 199–203. 114 indexed citations

Livingston, R. B., Lawrence H. Einhorn, M. A. Burgess, & Jeffrey A. Gottlieb. (1976). Sequential combination chemotherapy for advanced, recurrent, squamous carcinoma of the head and neck. Cancer Treatment Reviews. 60(1). 103–105. 10 indexed citations

Gutterman, Jordan U., George R. Blumenschein, Gabriel N. Hortobágyi, et al.. (1976). Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.. BMJ. 2(6046). 1222–1225. 61 indexed citations

Murphy, William K., R. B. Livingston, & Jeffrey A. Gottlieb. (1976). Phase I evaluation of anguidine. Proceedings of the American Association for Cancer Research. 17. 4 indexed citations

Benjamin, Robert S., et al.. (1976). Cyvadic VS cyvadact: A randomized trial of cyclophosphamide (CY), vincristine (V), and adriamycin (A), plus dacarbazine (DIC), or actinomycin D (DACT) in metastatic sarcomas. 17. 14 indexed citations

Rodriguez, Victorio, Jeffrey A. Gottlieb, M. A. Burgess, et al.. (1976). Phase i studies with baker's antifol (baf) (nsc 139105). Cancer. 38(2). 690–694. 8 indexed citations

10.

Gottlieb, Jeffrey A., E. J. Freireich, & Gerald P. Bodey. (1975). Preliminary clinical evaluation of piperazinedione (P), a new crystalline antibiotic. Proceedings of the American Association for Cancer Research. 16(66). 5 indexed citations

11.

Minow, Robert A., Jeffrey A. Gottlieb, & Emil J. Freireich. (1975). Electrocardiogram QRS voltage changes in adriamycin cardiomyopathy. Proceedings of the American Association for Cancer Research. 16(66). 5 indexed citations

12.

Minow, Robert A., Robert S. Benjamin, & Jeffrey A. Gottlieb. (1975). Concurrent cyclophosphamide (CTX), mediastinal radiotherapy (MXRT), and other factors increasing the risk of adriamycin (A) induced cardiomyopathy (CMY). Clinical research. 23(3). 1 indexed citations

13.

Tranum, Bill L., Arthur Haut, Saul E. Rivkin, et al.. (1975). A phase II study of methyl CCNU in the treatment of solid tumors and lymphomas: A Southwest oncology group study. Cancer. 35(4). 1148–1153. 26 indexed citations

14.

Livingston, Robert B., Lawrence H. Einhorn, Gerald P. Bodey, et al.. (1975). COMB (cyclophosphamide, oncovin, methyl-ccnu, and bleomycin): A four-drug combination in solid tumors. Cancer. 36(2). 327–332. 49 indexed citations

15.

Livingston, R. B., M. A. Burgess, & Jeffrey A. Gottlieb. (1974). Bleomycin, adriamycin, CCNU, oncovin, and nitrogen mustard (BACON) in squamous cancer. Proceedings of the American Association for Cancer Research. 15. 2 indexed citations

16.

Gottlieb, Jeffrey A. & Catherine Hill. (1974). Chemotherapy of Thyroid Cancer with Adriamycin. New England Journal of Medicine. 290(4). 193–197. 170 indexed citations

17.

Livingston, R. B., Gerald P. Bodey, Jeffrey A. Gottlieb, & Emil Frei. (1973). Kinetic scheduling of vincristine (NSC-67574) and bleomycin (NSC-125066) in patients with lung cancer and other malignant tumors.. PubMed. 57(2). 219–24. 31 indexed citations

18.

Drewinko, Benjamin & Jeffrey A. Gottlieb. (1973). Survival kinetics of cultured human lymphoma cells exposed to adriamycin.. PubMed. 33(6). 1141–5. 30 indexed citations

19.

LePage, G. A. & Jeffrey A. Gottlieb. (1973). Deoxythioguanosine and thioguanine. Clinical Pharmacology & Therapeutics. 14(6). 966–969. 2 indexed citations

20.

Hart, Jacqueline S., D H Ho, Stephen L. George, et al.. (1972). Cytokinetic and molecular pharmacology studies of arabinosylcytosine in metastatic melanoma.. PubMed. 32(12). 2711–6. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact